Table 3.
Baseline and last available LDCT screening findings of participants who died of pancreatic cancer within 24 months of their last LDCT screening: original reports versus re-review. The original reports did not document any pancreatic findings, whereas the re-review by experienced radiologists identified undocumented pancreatic findings in 42% of last available LDCT scans and 29% of baseline LDCT scans. This comparison highlights the importance of thoroughly examining the pancreas, even if it is not the primary focus of lung cancer screening.
Original report n = 14 (%) |
Re-review n = 14 (%) |
p-value | |
---|---|---|---|
Pancreatic lesion on the baseline LDCT Calcification(s) Atrophy/Fatty infiltration |
0 0 |
1 (14.3) 4 (28.6) |
1 0.09 |
Pancreatic lesion on the last LDCT Calcification(s) Atrophy/Fatty infiltration |
0 0 |
3 (21.4) 4 (28.6) |
0.22 0.09 |